本文已被:浏览 730次 下载 447次
Received:February 12, 2020 Published Online:October 20, 2020
Received:February 12, 2020 Published Online:October 20, 2020
中文摘要: 目的 观察双重血浆置换(DFPP)联合免疫抑制剂治疗抗中性粒细胞胞浆抗体(ANCA)相关性血管炎肾损害的疗效。
方法 选取2016年5月至2019年4月肾内科收治的12例确诊ANCA相关性血管炎(AASV)肾损害的患者,其中MPO-ANCA阳性组 7例,另外PR3-ANCA阳性组5例,均接受DFPP 治疗,同时联合使用甲泼尼龙及环磷酰胺进行冲击治疗,比较治疗前后病情活动指标和血清ANCA滴度、免疫球蛋白(Ig)G、血清白蛋白(ALB)、血肌酐(Scr)水平的变化。
结果 pANCA及MPO-ANCA 阳性组患者随访末,伯明翰血管炎活动性评分(BVAS)及MPO-ANCA滴度、Scr水平均比治疗前下降(P<0.05,P<0.01),24 h尿蛋白定量(Upro)、尿沉渣红细胞计数(URBC)、ALB、IgG水平与治疗前比较差异无统计学意义(P均>0.05);7例中1例进入维持性透析,6例部分缓解。cANCA及PR3-ANCA 阳性组患者随访末BVAS评分及ANCA滴度、Scr、URBC、ALB及IgG水平均比治疗前下降(P<0.05,P<0.01);5例中1例进入维持性透析,1例完全缓解,3例部分缓解,合计4例缓解。
结论 DFPP联合免疫抑制剂治疗能有效降低AASV肾损害患者的ANCA滴度,改善肾功能。
中文关键词: 双重血浆置换 免疫抑制剂 抗中性粒细胞胞浆抗体相关性血管炎 肾损害
Abstract:Objective To observe the curative efficacy of double filtration plasmapheresis (DFPP) combined with immunosuppressant on the treatment of anti-neutrophil cytoplasmic antibodies (ANCA)associated systemic vasculitis (AASV)with renal damage.
Methods Out of 12 patients diagnosed as AASV with renal damage treated from May 2016 to April 2019,there were 7 cases with positive MPO-ANCA group and 5 cases with positive PR3-ANCA group.All the patients were treated with DFPP combined with shock therapy of prednisolone and cyclophosphamide.The changes of disease activity index,ANCA titer,immunoglobulin G (Ig),serum albumin (ALB) and serum creatinine (Scr) were compared before and after treatment.
Results In positive MPO-ANCA group,Birmingham vasculitis activity score (BVAS),MPO-ANCA titer and Scr level were significantly lower at the end of follow-up than those before treatment (P<0.05,P<0.01),and there were no significant differences in 24-hour urinary protein quantity (Upro),urinary sediment red blood cell count (URBC),ALB and IgG (all P>0.05).One patient underwent maintenance dialysis,and 6 patients achieved partial remission.In positive PR3-ANCA group,BVAS,ANCA titer and the levels of Scr,URBC,ALB and IgG were significantly lower than those before treatment (P<0.05,P<0.01),and there were 1 case of undergoing maintenance dialysis,1 case of complete remission and 3 cases of partial remission.
Conclusion DFPP combined with immunosuppressive therapy can effectively reduce ANCA titer and improve renal function in AASV patients with renal damage.
keywords: Double filtration plasmapheresis Immunosuppressant Anti-neutrophil cytoplasmic antibodies associated systemic vasculitis Renal damage
文章编号: 中图分类号: 文献标志码:A
基金项目:广西第二批高校重点实验室开放项目科研课题(kfkt20160055)
引用文本: